(Q40430355)

20 September 2017

1 reference

title

Late effects of treatment in long-term survivors of cancer (English)

1 reference

20 September 2017

C. L. Schwartz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7585660

25 May 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7585660

25 May 2024

publication date

1 July 1995

1 reference

full work available at URL

20 September 2017

https://api.elsevier.com/content/article/PII:0305737295900373?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0305-7372(95)90037-3

https://api.elsevier.com/content/article/PII:0305737295900373?httpAccept=text/plain

25 May 2024

1 reference

https://api.crossref.org/works/10.1016/0305-7372(95)90037-3

25 May 2024

published in

Cancer Treatment Reviews

1 reference

20 September 2017

volume

21

1 reference

20 September 2017

issue

4

1 reference

20 September 2017

page(s)

355-366

1 reference

Breast hypoplasia following irradiation of the female breast in infancy and early childhood

20 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0305-7372(95)90037-3

Failure of development of the growing breast after radiation therapy

25 May 2024

2

1 reference

https://api.crossref.org/works/10.1016/0305-7372(95)90037-3

Failure of lactation following radiotherapy for breast cancer

25 May 2024

3

1 reference

https://api.crossref.org/works/10.1016/0305-7372(95)90037-3

Reduced pulsatile growth hormone secretion in children after therapy for acute lymphoblastic leukemia

25 May 2024

4

1 reference

https://api.crossref.org/works/10.1016/0305-7372(95)90037-3

Precocious or early puberty and growth failure in girls treated for acute lymphoblastic leukaemia

25 May 2024

5

1 reference

https://api.crossref.org/works/10.1016/0305-7372(95)90037-3

Cognitive deficits in long-term survivors of childhood brain tumors

25 May 2024

7

1 reference

https://api.crossref.org/works/10.1016/0305-7372(95)90037-3

CNS prophylaxis of childhood leukemia: what are the long-term neurological, neuropsychological, and behavioral effects?

25 May 2024

8

1 reference

https://api.crossref.org/works/10.1016/0305-7372(95)90037-3

Medulloblastoma in childhood: progressive intellectual deterioration.

25 May 2024

9

1 reference

https://api.crossref.org/works/10.1016/0305-7372(95)90037-3

Comparison of neuropsychologic functioning and clinical indicators of neurotoxicity in long-term survivors of childhood leukemia given cranial radiation or parenteral methotrexate: a prospective study

25 May 2024

10

1 reference

https://api.crossref.org/works/10.1016/0305-7372(95)90037-3

Educational, occupational, and insurance status of childhood cancer survivors in their fourth and fifth decades of life

25 May 2024

11

1 reference

https://api.crossref.org/works/10.1016/0305-7372(95)90037-3

Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood

25 May 2024

12

1 reference

https://api.crossref.org/works/10.1016/0305-7372(95)90037-3

Congestive heart failure due to adriamycin cardiotoxicity: its natural history in children

25 May 2024

13

1 reference

https://api.crossref.org/works/10.1016/0305-7372(95)90037-3

Radiation-induced heart disease: an update

25 May 2024

16

1 reference

https://api.crossref.org/works/10.1016/0305-7372(95)90037-3

Coronary artery disease mortality in patients treated for Hodgkin's disease

25 May 2024

17

1 reference

https://api.crossref.org/works/10.1016/0305-7372(95)90037-3

Factors affecting late mortality from heart disease after treatment of Hodgkin's disease

25 May 2024

18

1 reference

https://api.crossref.org/works/10.1016/0305-7372(95)90037-3

Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in childhood

25 May 2024

19

1 reference

https://api.crossref.org/works/10.1016/0305-7372(95)90037-3

Increased risk of lung cancer after breast cancer radiation therapy in cigarette smokers

25 May 2024

21

1 reference

https://api.crossref.org/works/10.1016/0305-7372(95)90037-3

Reproductive and endocrine gonadal functions in adults following multidrug chemotherapy for acute lymphoblastic or undifferentiated leukemia

25 May 2024

23

1 reference

https://api.crossref.org/works/10.1016/0305-7372(95)90037-3

Cyclophosphamide-induced ovarian failure and its therapeutic significance in patients with breast cancer

25 May 2024

24

1 reference

https://api.crossref.org/works/10.1016/0305-7372(95)90037-3

Early menopause in long-term survivors of cancer during adolescence

25 May 2024

25

1 reference

https://api.crossref.org/works/10.1016/0305-7372(95)90037-3

Recovery of spermatogenesis after treatment for Hodgkin's disease: limiting dose of MOPP chemotherapy

25 May 2024

27

1 reference

https://api.crossref.org/works/10.1016/0305-7372(95)90037-3

Radiation injury in the human kidney: a prospective analysis using specific scintigraphic and biochemical endpoints

25 May 2024

28

1 reference

https://api.crossref.org/works/10.1016/0305-7372(95)90037-3

Urinary Tract Toxic Effects of Cancer Therapy

25 May 2024

29

1 reference

https://api.crossref.org/works/10.1016/0305-7372(95)90037-3

Renal and electrolyte disturbances associated with cisplatin

25 May 2024

31

1 reference

https://api.crossref.org/works/10.1016/0305-7372(95)90037-3

Nephrotoxicity from chemotherapy: prevention and management

25 May 2024

32

1 reference

https://api.crossref.org/works/10.1016/0305-7372(95)90037-3

Nephrotoxicity after ifosfamide

25 May 2024

33

1 reference

https://api.crossref.org/works/10.1016/0305-7372(95)90037-3

Acute side effects and late complications after radiotherapy of localized carcinoma of the prostate

25 May 2024

34

1 reference

https://api.crossref.org/works/10.1016/0305-7372(95)90037-3

Urinary bladder tumors following cyclophosphamide therapy: a report of two cases with a review of the literature

25 May 2024

37

1 reference

https://api.crossref.org/works/10.1016/0305-7372(95)90037-3

Thyroid Diseases after Treatment of Hodgkin's Disease

25 May 2024

38

1 reference

https://api.crossref.org/works/10.1016/0305-7372(95)90037-3

Incidence of second primary tumours among childhood cancer survivors

25 May 2024

39

1 reference

https://api.crossref.org/works/10.1016/0305-7372(95)90037-3

Second malignant neoplasms in children: an update from the Late Effects Study Group

25 May 2024

40

1 reference

https://api.crossref.org/works/10.1016/0305-7372(95)90037-3

Inhibition of first-pass metabolism in cancer chemotherapy: interaction of 6-mercaptopurine and allopurinol

25 May 2024

41

1 reference

https://api.crossref.org/works/10.1016/0305-7372(95)90037-3

Clinical pharmacology of l-β-D-arabinofuranosyl cytosine

25 May 2024

42

1 reference

https://api.crossref.org/works/10.1016/0305-7372(95)90037-3

The Risk of Breast Cancer after Irradiation of the Thymus in Infancy

25 May 2024

43

1 reference

https://api.crossref.org/works/10.1016/0305-7372(95)90037-3

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms

25 May 2024

44

1 reference

https://api.crossref.org/works/10.1016/0305-7372(95)90037-3

Second primary neoplasms in patients with retinoblastoma

25 May 2024

45

1 reference

https://api.crossref.org/works/10.1016/0305-7372(95)90037-3

25 May 2024

Identifiers

1 reference

20 September 2017

1 reference